Skip to main
We’re doing some system maintenance

Posts & Investments - #omicron

📰 📺NEWS📺📰 U.S. FDA authorizes Pfizer's COVID-19 booster for 12- to 15-year-olds - Reuters #News #Stockmarket See more
0
0
Sold GrubHubInvested for 120 days
Lost43.44%
#taxlossharvesting 2 shares sold @ $10.60, bought at $18ish average. This has been red since day one and I don’t see obvious signs of this climbing back to my buy price. #omicron #stayathome might perk it up so I’ll keep an eye on it for possible re-entry in late January. They take a lot of restaurants’ profit though, making it hard for them to stay alive, so maybe I won’t bother.
0
0
Attention to IPO fans. I struggle with my recent IPO investments. But not much, because I didn’t invest more than 1% of my portfolio. Most IPOs are not a great idea to invest in December 2021-January 2020-till #omicron spike resolved. As you can see, most of IPOs were overrated in the start price and quickly wend down to 10% in average on the first week after going public. Keep watching! #ipoSee more
0
0
Just a tidbit on #COVID19 I had been told $PFE was the best vaccine out there next to Moderna.. until Omicron now word is the $MRNAbooster works best on omicron.See more
2
0
Invested in Pfizer
0
0
Sold Petroleo BrasileiroInvested for 221 days
Made28.65%
The chart repeats the beginning of 11/2019, which was followed by a huge drop. Even though that drop happened because of Covid, we are not sure if the gas will stay high when #Omicron hits developing countries. #gastainvierte
Tipped
0
0
SHOULD YOU BUY THIS #DIP, or HOLD CASH and wait to buy? I think this poll is a good indicator of what you should do. Which catalyst is creating the most fear.. in turn sell-offs. Omicron variant - 4 times contagious, but so far seems like symptoms are not severe. Evergrande- default, the unraveling of the world financial market. 12/10 CPI data - expected to be higher than 6% which is very high.See more
Omicron Variant 40.37%
Evergrande33.03%
12/10 CPI data10.09%
12/14 FOM Fed talk16.51%
109 votes Ended 12/17/21
12
0
Own your future.
Build your portfolio.
Products
Contact Us
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Market data powered by Xignite.

Brokerage services for US-listed, registered securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings, Inc. (“Public Holdings”). This is not an offer, solicitation of an offer, or advice to buy or sell securities or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Our clearing firm, Apex Clearing Corporation, has purchased an additional insurance policy. The coverage limits provide protection for securities and cash up to an aggregate of $150 million, subject to maximum limits of $37.5 million for any one customer’s securities and $900,000 for any one customer’s cash. Similar to SIPC protection, this additional insurance does not protect against a loss in the market value of securities.

Brokerage services for alternative assets available on Public are offered by Dalmore Group, LLC (“Dalmore”), member of FINRA & SIPC. “Alternative assets,” as the term is used at Public, are over-the-counter equity securities that have been issued pursuant to Regulation A of the Securities Act of 1933 (as amended) (“Regulation A”). Dalmore and Open to the Public Investing are not affiliated entities. This content is not investment advice. These investments are speculative, involve substantial risks (including illiquidity and loss of principal), and are not FDIC or SIPC insured. The issuers of these securities may be an affiliate of Public, and Public (or an affiliate) may earn fees when you purchase or sell Alternative Assets. For more information on risks and conflicts of interest, see these disclosures. An affiliate of Public may be “testing the waters” and considering making an offering of securities under Tier 2 of Regulation A. No money or other consideration is being solicited and, if sent in response, will not be accepted. No offer to buy securities can be accepted, and no part of the purchase price can be received, until an offering statement filed with the SEC has been qualified by the SEC. Any such offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time before notice of acceptance given after the date of qualification by the SEC or as stated in the offering materials relating to an investment opportunity, as applicable. An indication of interest to purchase securities involves no obligation or commitment of any kind.

Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Apex Crypto is not a registered broker-dealer or a member of SIPC or FINRA. Cryptocurrencies are not securities and are not FDIC or SIPC insured. Apex Crypto is licensed to engage in virtual currency business activity by the New York State Department of Financial Services. Please ensure that you fully understand the risks involved before trading: Legal Disclosures, Apex Crypto.

Dalmore and Apex Crypto, LLC are not affiliated with any of the Public Holdings subsidiaries.

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S.-listed, registered securities electronically. Keep in mind that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more. All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.